v3.25.2
Fair Value Measurements (Tables)
6 Months Ended
Jun. 30, 2025
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis

Our financial assets and (liabilities) carried at fair value and measured on a recurring basis as of June 30, 2025 and December 31, 2024 consisted of the following (in thousands):

Fair Value Measurements Using

Total Fair

Quoted prices in

Significant other

Significant

Value at

active markets

observable inputs

unobservable inputs

    

June 30, 2025

    

(Level 1)

    

(Level 2)

    

(Level 3)

Money market funds (1)

$

30,652

$

30,652

$

United States treasury debt securities (2)

$

7,718

$

7,718

$

Foreign currency contract assets, current and long-term (3)

$

5,271

$

$

5,271

$

Foreign currency contract liabilities, current and long-term (4)

$

(5,288)

$

$

(5,288)

$

Contingent consideration liabilities

$

(2,027)

$

$

$

(2,027)

Fair Value Measurements Using

Total Fair

Quoted prices in

Significant other

Significant

Value at

active markets

observable inputs

unobservable inputs

    

December 31, 2024

    

(Level 1)

    

(Level 2)

    

(Level 3)

Money market funds (1)

$

10,034

$

10,034

$

Marketable securities (5)

$

92

$

92

$

Foreign currency contract assets, current and long-term (3)

$

7,430

$

$

7,430

$

Foreign currency contract liabilities, current and long-term (4)

$

(2,907)

$

$

(2,907)

$

Contingent consideration liabilities

$

(3,486)

$

$

$

(3,486)

(1)Our money market fund represents a bank-managed money market fund which permits daily redemptions. Amounts in the fund are recorded as cash equivalents in the consolidated balance sheets.
(2)The fair value of U.S. treasury debt securities are determined using quoted prices for identical assets in active markets and is recorded as cash and cash equivalents in the consolidated balance sheets.
(3)The fair value of the foreign currency contract assets (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as a prepaid expense and other current asset or other long-term asset in the consolidated balance sheets.
(4)The fair value of the foreign currency contract liabilities (including those designated as hedging instruments and those not designated as hedging instruments) is determined using Level 2 fair value inputs and is recorded as accrued expense or other long-term obligation in the consolidated balance sheets.
(5)Our marketable securities, which consist entirely of available-for-sale equity securities, are valued using market prices in active markets. Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets.
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation Changes in the fair value of our contingent consideration liabilities during the three and six-month periods ended June 30, 2025 and 2024 consisted of the following (in thousands):

    

Three Months Ended

    

Six Months Ended

    

June 30, 

    

June 30, 

    

2025

    

2024

    

2025

    

2024

Beginning balance

$

4,429

$

3,225

$

3,486

$

3,447

Contingent consideration expense

 

143

 

305

 

1,166

 

188

Contingent payments made

 

(2,545)

 

(95)

 

(2,625)

 

(200)

Ending balance

$

2,027

$

3,435

$

2,027

$

3,435

Fair Value Inputs, Liabilities, Quantitative Information

The recurring Level 3 measurement of our contingent consideration liabilities included the following significant unobservable inputs at June 30, 2025 and December 31, 2024 (amounts in thousands):

Fair value at

    

June 30, 

Valuation

Weighted

Contingent consideration liability

    

2025

    

technique

    

Unobservable inputs

    

Range

Average(1)

Revenue-based royalty payments contingent liability

$

1,936

 

Discounted cash flow

 

Discount rate

13.0% - 15.0%

13.5%

 

  

 

 

Projected year of payments

2025-2034

2029

Revenue milestones contingent liability

$

91

 

Monte Carlo simulation

 

Discount rate

11.0%

 

  

 

 

Projected year of payments

2025-2041

2041

Fair value at

    

December 31, 

Valuation

Weighted

Contingent consideration liability

    

2024

    

technique

    

Unobservable inputs

    

Range

Average(1)

Revenue-based royalty payments contingent liability

$

2,217

 

Discounted cash flow

 

Discount rate

14.0% - 16.0%

14.6%

 

  

 

 

Projected year of payments

2025-2034

2028

Revenue milestones contingent liability

$

88

 

Monte Carlo simulation

 

Discount rate

13.0%

 

  

 

 

Projected year of payments

2025-2040

2039

Regulatory approval contingent liability

$

1,181

Scenario-based method

Discount rate

6.0%

Probability of milestone payment

50.0%

Projected year of payment

2025-2026

2025

(1)Unobservable inputs were weighted by the relative fair value of the instruments. No weighted average is reported for contingent consideration liabilities without a range of unobservable inputs.
Schedule of Rollforward of Allowance for Credit Losses

The table below presents a roll-forward of the allowance for current expected credit losses on our notes receivable for the three and six-month periods ended June 30, 2025 and 2024 (in thousands):

Three Months Ended

Six Months Ended

June 30, 

June 30, 

2025

    

2024

2025

    

2024

Beginning balance

$

1,634

$

1,388

$

1,366

$

568

Provision for credit loss expense

741

18

1,009

838

Ending balance

$

2,375

$

1,406

$

2,375

$

1,406